PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1727
https://www.valueinhealthjournal.com/article/S1098-3015(12)03440-7/fulltext
Title :
PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Comparative Effectiveness Analysis Using Indirect Statistical Techniques
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03440-7&doi=10.1016/j.jval.2012.08.1727
First page :
A508
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
1214